• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Helicos BioSciences Corp.

Helicos delisted

November 16, 2010 By MassDevice staff Leave a Comment

HLCS logo

Helicos Biosciences Corp. (OTC:HLCS) was delisted from the NASDAQ stock market today.

The Cambridge, Mass.-based developer of genomics instruments said in a Securities & Exchange Commission filing that "the state of its finances and near-term business prospects" made it "unlikely" for the company to reach the minimum market value of listed securities per NASDAQ’s rules, including a per share value of at least $1.

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, News Well Tagged With: Helicos BioSciences Corp.

Helicos taps Trifunovich for CEO, announces single-molecule sequence licensing

October 15, 2010 By MassDevice staff Leave a Comment

HLCS logo

Ivan Trifunovich will be occupying the corner office at Helicos BioSciences Corp. (NSDQ:HLCS), as the company rolls out a new licensing program for its single-molecule gene sequencing technology.

Trifunovich, formerly a senior consultant to the Helicos board, was elected to serve as executive chairman Sept. 15. He replaces interim CEO Ronald Lowy, who took over from Stephen Lombardi in February and will remain a board member.

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, News Well Tagged With: Helicos BioSciences Corp., Personnel Moves

Helicos slaps Pacific Biosciences with patent infringement suit

September 1, 2010 By MassDevice staff Leave a Comment

HLCS, Pacific Biosciences logos

Helicos Biosciences Corp. (NSDQ:HLCS) slapped competitor Pacific Biosciences of California Inc. with a patent infringement lawsuit alleging that Pacific’s SMRT single-molecule DNA sequencing technology violates a quartet of Helicos patents.

The lawsuit, filed Aug. 27 in the U.S. District Court for Delaware by Cambridge, Mass.-based Helicos, accuses Pacific Biosciences of infringing two patents it owns and another two it licenses, covering sequencing-by-synthesis methods that use labeled nucleotides to analyze single strands of DNA.

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, News Well Tagged With: Helicos BioSciences Corp., Pacific Biosciences Inc.

Researchers use Helicos platform to find evidence of RNA copying in human cells

August 2, 2010 By MassDevice staff Leave a Comment

HLCS logo

Helicos BioSciences Corp.’s (NSDQ:HLCS) technology continues to prove useful on the cutting edge of cancer research.

Pittsburgh School of Medicine scientists employed the Cambridge, Mass.-based company’s single-molecule sequencing platform find evidence of RNA copying mechanisms in human cells.

The results showed that SMS technology could become an important part of comprehensive genetic profiling, according to Pitt assistant professor of computational biology Bino John.

Filed Under: Business/Financial News, Diagnostics, News Well, Oncology Tagged With: Helicos BioSciences Corp.

MGH cancer researchers use Helicos platform to ID genes

July 20, 2010 By MassDevice staff Leave a Comment

HLCS logo

Helicos BioSciences Corp. (NSDQ:HLCS) teamed up with cancer researchers at Massachusetts General Hospital to demonstrate the clinical utility of Helicos’ single molecule sequencing platform.

Daniel Haber, director of MGH’s Cancer Center, and his colleagues published their findings online in Nature Methods.

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, News Well, Oncology Tagged With: Helicos BioSciences Corp.

Helicos BioSciences launches diagnostics business

June 25, 2010 By MassDevice staff Leave a Comment

HLCS logo

Helicos BioSciences Corp. (NSDQ:HLCS) launched a new molecular diagnostics business using its HeliScope single molecule sequencer after a significant restructuring.

In May, the company laid off half its workforce in a bid to capture more of the molecular diagnostics market.

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, News Well Tagged With: Helicos BioSciences Corp.

Raindance adds IP counsel in leadership role

June 23, 2010 By MassDevice staff Leave a Comment

RainDance logo

RainDance Technologies Inc. today announced the addition of Alan Sherr as VP and chief intellectual property counsel.

Sherr will lead the growth and management of Raindance’s IP portfolio, elements of which comprise the company’s "disruptive microdroplet platform technology" used in single-molecule and single-cell analysis.

Filed Under: Business/Financial News, Diagnostics, Lab Instruments & Supplies, News Well Tagged With: Helicos BioSciences Corp., RainDance Technologies Inc.

Helicos to exit drug discovery business, lays off 40 workers

May 18, 2010 By MassDevice staff Leave a Comment

Helicos BioSciences Corp. (NASDAQ:HLCS) is eliminating 40 jobs, or about half of its current workforce, as it gives up on its genetic analysis and drug discovery business to instead focus solely on the molecular diagnostics market.

The Cambridge, Mass.-based genomics company said last month it was exploring strategic alternatives to take better advantage of its DNA-sequencing technology and to address current and potential competition. The firm received orders for 10 of its Helicos Systems during 2009 but was able to fully recognize only two of those sales in last year’s financial results, generating $2.3 million in reported revenues.

Filed Under: Business/Financial News, Diagnostics, News Well Tagged With: 2010, Helicos BioSciences Corp.

Helicos BioSciences hit with possible de-listing notice

April 16, 2010 By MassDevice staff Leave a Comment

HCLS logo

Market regulators are threatening to de-list Helicos BioSciences Corp. (NSDQ:HCLS) unless the gene sequencing firm can coax its share price above $1 for more than 10 days.

Officials at the Cambridge, Mass.-based firm received a letter earlier this week that the bid price of its stock has closed below $1 a share for more than 30 consecutive business days, triggering a 180-day window for Helicos to get its stock price above that threshold for at least two weeks or risk de-listing from the NASDAQ Global Market.

Filed Under: Business/Financial News, News Well, Research & Development Tagged With: Helicos BioSciences Corp.

Helicos president Lombardi resigns

February 15, 2010 By MassDevice staff Leave a Comment

Helicos BioSciences Corp. (NSDQ:HLCS) president Stephen Lombardi is out effective Feb. 11, replaced by CEO Ronald Lowy for unspecified reasons, according to a filing with the federal Securities and Exchange Commission.

Lombardi, who also gave up his seat on the Cambridge, Mass.-based genome sequencing equipment maker, will be paid the balance of his $375,000 annual salary through August.

"Mr. Lombardi did not resign as a member of the Board of Directors as a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices," according to the filing.

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, News Well Tagged With: Helicos BioSciences Corp.

Helicos loses a lap to Illumina in race for cheap genome sequencing

January 13, 2010 By MassDevice staff Leave a Comment

Illumina Inc. (NSDQ:ILMN) put some distance between itself and its competitors this week, as it revealed equipment capable of sequencingthe human genome for less than $10,000.

The San Diego-based company unveiled its HiSeq 2000 at the annual J.P. Morgan Health Care Conference in San Francisco, where CEO Jay Flatley said a Hong Kong-based genomics institute called BGI bought 128 of the $690,000 systems, according to the Wall Street Journal.

Filed Under: Business/Financial News, Diagnostics, Genomics/Molecular Diagnostics, News Well Tagged With: Helicos BioSciences Corp., Illumina Inc., Life Technologies Corp., Pacific Biosciences Inc.

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS